Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Reassessing therapeutic antibodies for neglected and tropical diseases.

Hooft van Huijsduijnen R, Kojima S, Carter D, Okabe H, Sato A, Akahata W, Wells TNC, Katsuno K.

PLoS Negl Trop Dis. 2020 Jan 30;14(1):e0007860. doi: 10.1371/journal.pntd.0007860. eCollection 2020 Jan. Review.

2.

An isoform-selective inhibitor of tropomyosin receptor kinase A behaves as molecular glue.

Furuya N, Momose T, Katsuno K, Fushimi N, Muranaka H, Handa C, Sawa M, Ozawa T, Kinoshita T.

Bioorg Med Chem Lett. 2020 Jan 1;30(1):126775. doi: 10.1016/j.bmcl.2019.126775. Epub 2019 Oct 28.

PMID:
31699609
3.

Bringing Japan's R&D innovation and leadership to combat neglected diseases.

Katsuno K.

Nihon Yakurigaku Zasshi. 2017;149(5):231-234. doi: 10.1254/fpj.149.231. Japanese. No abstract available.

PMID:
28484106
4.

The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity.

Furuya N, Momose T, Katsuno K, Fushimi N, Muranaka H, Handa C, Ozawa T, Kinoshita T.

Bioorg Med Chem Lett. 2017 Mar 1;27(5):1233-1236. doi: 10.1016/j.bmcl.2017.01.056. Epub 2017 Jan 21.

PMID:
28159414
5.

Synthesis and structure-activity relationships of 1-benzylindane derivatives as selective agonists for estrogen receptor beta.

Yonekubo S, Fushimi N, Miyagi T, Nakanishi O, Katsuno K, Ozawa M, Handa C, Furuya N, Muranaka H.

Bioorg Med Chem. 2016 Nov 15;24(22):5895-5910. doi: 10.1016/j.bmc.2016.09.047. Epub 2016 Sep 20.

PMID:
27692995
6.

Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice.

Nakano S, Katsuno K, Isaji M, Nagasawa T, Buehrer B, Walker S, Wilkison WO, Cheatham B.

J Clin Exp Hepatol. 2015 Sep;5(3):190-8. doi: 10.1016/j.jceh.2015.02.005. Epub 2015 Apr 28.

7.

Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Katsuno K, Burrows JN, Duncan K, Hooft van Huijsduijnen R, Kaneko T, Kita K, Mowbray CE, Schmatz D, Warner P, Slingsby BT.

Nat Rev Drug Discov. 2015 Nov;14(11):751-8. doi: 10.1038/nrd4683. Epub 2015 Oct 5. Review.

PMID:
26435527
8.

Addition of exogenous NAD+ prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic cultures.

Ding D, Qi W, Yu D, Jiang H, Han C, Kim MJ, Katsuno K, Hsieh YH, Miyakawa T, Salvi R, Tanokura M, Someya S.

PLoS One. 2013 Nov 6;8(11):e79817. doi: 10.1371/journal.pone.0079817. eCollection 2013.

9.

Effect of immobile impurities on two-dimensional nucleation.

Katsuno H, Katsuno K, Sato M.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Aug;84(2 Pt 1):021605. Epub 2011 Aug 23.

PMID:
21928997
10.

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.

Katsuno K, Fujimori Y, Ishikawa-Takemura Y, Isaji M.

Eur J Pharmacol. 2009 Sep 15;618(1-3):98-104. doi: 10.1016/j.ejphar.2009.07.001. Epub 2009 Jul 15.

PMID:
19615995
11.

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.

Fujimori Y, Katsuno K, Ojima K, Nakashima I, Nakano S, Ishikawa-Takemura Y, Kusama H, Isaji M.

Eur J Pharmacol. 2009 May 1;609(1-3):148-54. doi: 10.1016/j.ejphar.2009.03.007. Epub 2009 Mar 10.

PMID:
19281809
12.

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models.

Fujimori Y, Katsuno K, Nakashima I, Ishikawa-Takemura Y, Fujikura H, Isaji M.

J Pharmacol Exp Ther. 2008 Oct;327(1):268-76. doi: 10.1124/jpet.108.140210. Epub 2008 Jun 26.

PMID:
18583547
13.

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level.

Katsuno K, Fujimori Y, Takemura Y, Hiratochi M, Itoh F, Komatsu Y, Fujikura H, Isaji M.

J Pharmacol Exp Ther. 2007 Jan;320(1):323-30. Epub 2006 Oct 18.

PMID:
17050778
14.

Effective stabilisation of alpha-helical structures in short peptides with acetylenic cross-linking agents.

Fujimoto K, Oimoto N, Katsuno K, Inouye M.

Chem Commun (Camb). 2004 Jun 7;(11):1280-1. Epub 2004 May 10. No abstract available.

PMID:
15154036
15.

Adverse effect of dentine bonding agent on the oral mucosa of guinea pigs.

Manabe A, Katsuno K, Kurihara A, Itoh K, Hisamitsu H, Wakumoto S, Iijima M, Yoshida T.

J Oral Rehabil. 2001 Jan;28(1):88-94.

PMID:
11298914
16.

Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody.

Karube Y, Katsuno K, Ito S, Matsunaga K, Takata J, Kuroki M, Murakami M, Matsuoka Y.

Ann Nucl Med. 1999 Dec;13(6):407-13.

PMID:
10656275
17.

[Baeyer-Villiger reaction of benzaldehydes possessing oxygen functions with SeO2-H2O2].

Nishioka H, Katsuno K, Fujii M, Nishita Y, Koshiba N, Harayama T.

Yakugaku Zasshi. 1999 Jul;119(7):519-28. Japanese.

PMID:
10434804
18.

Tranilast inhibits the proliferation of human coronary smooth muscle cell through the activation of p21waf1.

Kusama H, Kikuchi S, Tazawa S, Katsuno K, Baba Y, Zhai YL, Nikaido T, Fujii S.

Atherosclerosis. 1999 Apr;143(2):307-13.

PMID:
10217359
19.

Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.

Segawa Y, Shirao Y, Yamagishi S, Higashide T, Kobayashi M, Katsuno K, Iyobe A, Harada H, Sato F, Miyata H, Asai H, Nishimura A, Takahira M, Souno T, Segawa Y, Maeda K, Shima K, Mizuno A, Yamamoto H, Kawasaki K.

Ophthalmic Res. 1998;30(6):333-9.

PMID:
9731114
20.

The adverse effect of commercial dentine-bonding systems on the skin of guinea pigs.

Katsuno K, Manabe A, Kurihara A, Itoh K, Hisamitsu H, Wakumoto S, Yoshida T.

J Oral Rehabil. 1998 Mar;25(3):180-4.

PMID:
9578224
21.

Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor.

Yamagishi Si, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H.

J Biol Chem. 1997 Mar 28;272(13):8723-30.

22.

Evaluation of skin irritation and sensitization of two diol solutions used as experimental dentin primers in humans and guinea pigs.

Kurihara A, Manabe A, Katsuno K, Itoh K, Hisamitsu H, Wakumoto S, Yoshida T.

Dent Mater J. 1996 Dec;15(2):226-32.

23.

Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor.

Karube Y, Katsuno K, Takata J, Matsunaga K, Haruno M, Kuroki M, Arakawa F, Matsuoka Y, Kanda H.

Nucl Med Biol. 1996 Aug;23(6):753-9.

PMID:
8940717
24.

Contact dermatitis caused by 2-HEMA and GM dentin primer solutions applied to guinea pigs and humans.

Katsuno K, Manabe A, Itoh K, Nakamura Y, Wakumoto S, Hisamitsu H, Yoshida T.

Dent Mater J. 1996 Jun;15(1):22-30.

25.

In vitro properties and in vivo behavior of technetium-99m labeled fibrinogens.

Karube Y, Ito S, Katsuno K, Takata J.

Ann Nucl Med. 1996 Feb;10(1):63-9.

PMID:
8814729
26.

Peak oxygen uptake and respiratory function in persons with spinal cord injury.

Yamasaki M, Komura T, Tahara Y, Katsuno K, Fukuyama Y, Michimuko R, Fujiie K.

Appl Human Sci. 1996 Jan;15(1):14-7.

27.

[Hydrostatic weighing, skinfold thickness, body mass index relationships in high school girls].

Tahara Y, Yukawa K, Tsunawake N, Saeki S, Nishiyama K, Urata H, Katsuno K, Fukuyama Y, Michimukou R, Uekata M.

Nihon Koshu Eisei Zasshi. 1995 Dec;42(12):1061-8. Japanese.

PMID:
8835017
28.

[Body density assessment utilizing skinfold thickness and age in Japanese men].

Tahara Y, Yukawa K, Tsunawake N, Saeki S, Nishiyama K, Urata H, Katsuno K, Fukuyama Y, Michimuko R, Uekata M, et al.

Nihon Koshu Eisei Zasshi. 1995 Nov;42(11):950-61. Japanese.

PMID:
8547690
29.

A delayed hypersensitivity reaction to dentine primer in the guinea-pig.

Katsuno K, Manabe A, Itoh K, Hisamitsu H, Wakumoto S, Nakayama S, Yoshida T.

J Dent. 1995 Oct;23(5):295-9.

PMID:
7560376
30.

[Body density assessment utilizing skinfold thickness and age in Japanese women].

Tahara Y, Yukawa K, Tsunawake N, Saeki S, Nishiyama K, Urata H, Katsuno K, Fukuyama Y, Michimukou R, Moji K, et al.

Nihon Koshu Eisei Zasshi. 1995 Feb;42(2):84-94. Japanese.

PMID:
7718912
32.

[Sex differences in interrelationships between percent body fat (%fat) and waist-to-hip ratio (WHR) in healthy male and female adults].

Tahara Y, Tsunawake N, Yukawa K, Yamasaki M, Nishiyama K, Urata H, Katsuno K, Fukuyama Y.

Ann Physiol Anthropol. 1994 Sep;13(5):293-301. Japanese.

PMID:
7872985
33.

Mental and physical health of middle-aged and elderly women and psychosocial factors.

Ohta Y, Tsukahara M, Sugasaki H, Katsuno K, Uemura M.

Jpn J Psychiatry Neurol. 1993 Dec;47(4):735-42.

PMID:
8201787
34.

[Body composition (densitometry-hydrostatics), skinfold thickness, BMI and their relationships in junior high school girls].

Tahara Y, Yukawa K, Tsunawake N, Saeki S, Nishiyama K, Urata H, Katsuno K, Fukuyama Y.

Nihon Koshu Eisei Zasshi. 1993 May;40(5):353-62. Japanese.

PMID:
8329755
35.

Possibility of allergic reaction to dentin primer--application on the skin of guinea pigs.

Katsuno K, Manabe A, Hasegawa T, Nakayama S, Itoh K, Wakumoto S, Hisamitsu H.

Dent Mater J. 1992 Jun;11(1):77-82.

36.

Bonding efficacy of erythritol methacrylate solutions as dentin primers.

Manabe A, Katsuno K, Itoh K, Wakumoto S, Miyasaka T.

J Dent Res. 1991 Sep;70(9):1294-8.

PMID:
1918579
37.

Reliability and validity of the Childhood Autism Rating Scale--Tokyo version (CARS-TV).

Kurita H, Miyake Y, Katsuno K.

J Autism Dev Disord. 1989 Sep;19(3):389-96.

PMID:
2793784
38.

[Lipid constituent of the gallbladder mucosa, with reference to the origin of cholesterosis of the gallbladder].

Katsuno K.

Igaku Kenkyu. 1967 Nov;37(6):609-25. Japanese. No abstract available.

PMID:
5627046
39.

Supplemental Content

Loading ...
Support Center